Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released Aug 2, 2023, after the close
10-Q filed Aug 3, 2023, 34 days after period end · 0000950170-23-037458
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $165.24M | $134.56M | $115.22M | $110.10M |
| Net Income | $1.11M | -$34.01M | -$43.87M | -$42.14M |
| EPS Diluted |
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
| $0.01 |
| -$0.21 |
| -$0.27 |
| -$0.27 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
